Limitation of thrombin generation, platelet activation, and inflammation by elimination of cardiotomy suction in patients undergoing coronary artery bypass grafting treated with heparin-bonded circuits. [electronic resource]
Producer: 20020607Description: 742-55 p. digitalISSN:- 0022-5223
- Aged
- Anticoagulants -- therapeutic use
- Biomarkers -- blood
- Cardiopulmonary Bypass
- Coated Materials, Biocompatible -- therapeutic use
- Complement Membrane Attack Complex -- drug effects
- Coronary Artery Bypass
- Endpoint Determination
- Equipment Design
- Female
- Heparin -- therapeutic use
- Humans
- Inflammation Mediators -- blood
- Interleukin-6 -- blood
- Interleukin-8 -- blood
- Leukocyte Elastase -- blood
- Male
- Middle Aged
- Platelet Activation -- drug effects
- Prospective Studies
- Statistics as Topic
- Suction
- Thrombin -- biosynthesis
- Time Factors
- Treatment Outcome
- Washington
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Evaluation Study; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.